Skip to main content

Peer Review reports

From: PolyMyalgia Rheumatica treatment with Methotrexate in Optimal Dose in an Early disease phase (PMR MODE): study protocol for a multicenter double-blind placebo controlled trial

Original Submission
28 Sep 2021 Submitted Original manuscript
13 Dec 2021 Reviewed Reviewer Report - Kirsty Loudon
21 Dec 2021 Author responded Author comments - Thomas Eppo Bolhuis
Resubmission - Version 2
21 Dec 2021 Submitted Manuscript version 2
31 Mar 2022 Editorially accepted
15 Apr 2022 Article published 10.1186/s13063-022-06263-3

You can find further information about peer review here.

Back to article page